GILBERTO DELRIOVIVES: Open Payments
NPI 1528714953 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 40 payments from 16 companies in 2025. Trend: 2023 $440 · 2024 $520 · 2025 $855
Food & beverage: $855
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $227 |
| UCB, Inc. | 8 | $168 |
| SANOFI-AVENTIS U.S. LLC | 3 | $64 |
| Eisai Inc. | 2 | $56 |
| Astellas Pharma US Inc | 2 | $44 |
| Amgen Inc. | 3 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $39 |
| ARGENX US, INC. | 1 | $33 |
| Inspire Medical Systems, Inc. | 1 | $26 |
Products named: TREMFYA, Bimzelx, Leqembi, TZIELD, Veozah, Kerendia, Rystiggo, VYVGART HYTRULO.
Industry payments across GA — which companies pay providers there.
